Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.
- DOI
- 10.1016/j.ad.2025.104531
- Published
- 2026 Mar
- Container
- Actas dermo-sifiliograficas
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ad.2025.104531,
title = {Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.},
author = {Mansilla-Polo M and Pons-Benavent M and Fernández-Crehuet P and Vilarrasa E and Albanell-Fernández C and Morales-Tedone E and Rausell-Félix F and Alcalá-García R and Matellanes-Palacios M and Martín-Ezquerra G and Alfageme F and Ciudad-Blanco C and López-Villaescusa MT and Segura-Palacios JM and Pascual-Ramírez JC and Fernández-Díaz ML and Falkenhain-López D and García-Gil M and Agustí-Mejías A and No-Pérez N and Naranjo-Guerrero N and Estenaga-Pérez Á and García-Ruiz R and Mahiques-Santos L and Garbayo-Salmons P and Martorell A and Escutia-Muñoz B and Martín-Torregrosa D and Cuenca-Barrales C and Paniego CU and Botella-Estrada R and Molina-Leyva A and Spanish hidradenitis suppurativa group (GEHS)},
year = {2026},
journal = {Actas dermo-sifiliograficas},
doi = {10.1016/j.ad.2025.104531},
url = {https://doi.org/10.1016/j.ad.2025.104531}
}RIS
TY - JOUR TI - Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study. AU - Mansilla-Polo M AU - Pons-Benavent M AU - Fernández-Crehuet P AU - Vilarrasa E AU - Albanell-Fernández C AU - Morales-Tedone E AU - Rausell-Félix F AU - Alcalá-García R AU - Matellanes-Palacios M AU - Martín-Ezquerra G AU - Alfageme F AU - Ciudad-Blanco C AU - López-Villaescusa MT AU - Segura-Palacios JM AU - Pascual-Ramírez JC AU - Fernández-Díaz ML AU - Falkenhain-López D AU - García-Gil M AU - Agustí-Mejías A AU - No-Pérez N AU - Naranjo-Guerrero N AU - Estenaga-Pérez Á AU - García-Ruiz R AU - Mahiques-Santos L AU - Garbayo-Salmons P AU - Martorell A AU - Escutia-Muñoz B AU - Martín-Torregrosa D AU - Cuenca-Barrales C AU - Paniego CU AU - Botella-Estrada R AU - Molina-Leyva A AU - Spanish hidradenitis suppurativa group (GEHS) PY - 2026 JO - Actas dermo-sifiliograficas DO - 10.1016/j.ad.2025.104531 UR - https://doi.org/10.1016/j.ad.2025.104531 ER -
APA
M, M., M, P., P, F., E, V., C, A., E, M., F, R., R, A., M, M., G, M., F, A., C, C., MT, L., JM, S., JC, P., ML, F., D, F., M, G., A, A., N, N., N, N., Á, E., R, G., L, M., P, G., A, M., B, E., D, M., C, C., CU, P., R, B., A, M., & (GEHS), S. H. S. G. (2026). Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.. Actas dermo-sifiliograficas. https://doi.org/10.1016/j.ad.2025.104531
Source records
- pubmed · retrieved 2026-09-26T14:08:08.483Z